An authorized generic of Corgard was sold before, but it isn’t sold now. Ask your pharmacist whether a regular generic (nadolol) is available.
Source: FDA, updated October 30, 2026
Generic name: nadolol
Used for: High blood pressure · Chest pain from heart disease (angina) · 1 more
From
$14.08 for 30 tablets delivered ($8.83 plus $5.25 shipping)
Generic nadolol from Cost Plus Drugs, by mail. Pick the strength on your label above for its own price.
Need it today? From $15.97 for 30 tablets with the free Team Cuban Card, at pharmacies that take it. Get the free card and show it there.
See the price and get the cardA regular generic has the same active ingredient as Corgard, and the FDA requires it to work the same way.
Details for each option
Corgard itself isn’t sold as a prescription anymore. Its generic versions, if any, are in the other tabs.
An authorized generic of Corgard was sold before, but it isn’t sold now. Ask your pharmacist whether a regular generic (nadolol) is available.
Source: FDA, updated October 30, 2026
Pharmacies’ own cash prices for generic nadolol, lowest first.
Pick up in storeDelivered
From each pharmacy’s own site, read November 2, 2026. Confirm the price before you fill.
Prices change, can differ by store and state, and may depend on the strength and how many you take. With insurance, ask what your plan charges; it can be less.
7 companies sell a generic of Corgard that the FDA rates a substitute. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.
Has a dye: FD&C Blue No. 2
20 mg Light blue to blue color, round, 6 mm, marked “L / 19”
| Package | NDC |
|---|---|
| Bottle of 30 | 62332-402-30 |
| Bottle of 100 | 62332-402-31 |
| Bottle of 1000 | 62332-402-91 |
40 mg Light blue to blue color, round, 9 mm, marked “L / 713”
| Package | NDC |
|---|---|
| Bottle of 30 | 62332-403-30 |
| Bottle of 100 | 62332-403-31 |
| Bottle of 1000 | 62332-403-91 |
80 mg Light blue to blue color, round, 11 mm, marked “L / 714”
| Package | NDC |
|---|---|
| Bottle of 30 | 62332-404-30 |
| Bottle of 100 | 62332-404-31 |
| Bottle of 1000 | 62332-404-91 |
Inactive ingredients: povidone k30, starch, corn, microcrystalline cellulose, citric acid monohydrate, FD&C Blue No. 2, magnesium stearate
20 mg Off-white, round, 7 mm, marked “AA / 76”
| Package | NDC |
|---|---|
| Bottle of 30 | 69238-1123-3 |
| Bottle of 90 | 69238-1123-9 |
| Bottle of 1000 | 69238-1123-1 |
40 mg Off-white, round, 9 mm, marked “AA / 79”
| Package | NDC |
|---|---|
| Bottle of 30 | 69238-1124-3 |
| Bottle of 90 | 69238-1124-9 |
| Bottle of 1000 | 69238-1124-1 |
80 mg Off-white, round, 11 mm, marked “AA / 99”
| Package | NDC |
|---|---|
| Bottle of 30 | 69238-1125-3 |
| Bottle of 90 | 69238-1125-9 |
| Bottle of 1000 | 69238-1125-1 |
Inactive ingredients: cellulose, microcrystalline, magnesium stearate, povidone, starch, corn
Has a dye: FD&C Blue No. 2
Product page on aurobindousa.com
20 mg Light Blue, round, 6 mm, marked “NA / 20”
| Package | NDC |
|---|---|
| Bottle of 100 | 59651-589-01 |
40 mg Light Blue, round, 9 mm, marked “NA / 40”
| Package | NDC |
|---|---|
| Bottle of 100 | 59651-251-01 |
80 mg Light Blue, round, 11 mm, marked “NA / 80”
| Package | NDC |
|---|---|
| Bottle of 100 | 59651-252-01 |
Inactive ingredients: anhydrous citric acid, starch, corn, FD&C Blue No. 2, magnesium stearate, microcrystalline cellulose 101, microcrystalline cellulose 112, povidone k90
Has a dye: FD&C Blue No. 2 · Made by Aurobindo Pharma and Regcon Holdings
20 mg Blue, round, 7 mm, marked “020”
| Package | NDC |
|---|---|
| Bottle of 100 | 68001-630-00 |
20 mg Light Blue, round, 6 mm, marked “NA / 20”
| Package | NDC |
|---|---|
| Bottle of 100 | 68001-690-00 |
40 mg Blue, round, 9 mm, marked “021”
| Package | NDC |
|---|---|
| Bottle of 100 | 68001-631-00 |
40 mg Light Blue, round, 9 mm, marked “NA / 40”
| Package | NDC |
|---|---|
| Bottle of 100 | 68001-691-00 |
80 mg Blue, round, 9 mm, marked “022”
| Package | NDC |
|---|---|
| Bottle of 100 | 68001-632-00 |
80 mg Light Blue, round, 11 mm, marked “NA / 80”
| Package | NDC |
|---|---|
| Bottle of 100 | 68001-692-00 |
Inactive ingredients: FD&C Blue No. 2, starch, corn, magnesium stearate, cellulose, microcrystalline, citric acid monohydrate, copovidone, sodium starch glycolate type a corn, anhydrous citric acid, microcrystalline cellulose 101, microcrystalline cellulose 112, povidone k90
Has lactose · Has a dye: D&C Yellow No. 10 · Made by Invagen Pharmaceuticals
20 mg Yellow, round, 7 mm, marked “IG / 347”
| Package | NDC |
|---|---|
| Bottle of 100 | 76282-347-01 |
40 mg Yellow, round, 9 mm, marked “IG / 348”
| Package | NDC |
|---|---|
| Bottle of 100 | 76282-348-01 |
80 mg Yellow, round, 12 mm, marked “IG / 349”
| Package | NDC |
|---|---|
| Bottle of 100 | 76282-349-01 |
Inactive ingredients: lactose monohydrate, microcrystalline cellulose, povidone, D&C Yellow No. 10, croscarmellose sodium, magnesium stearate
Has a dye: FD&C Blue No. 2 · Made by Regcon Holdings
Product page on unichemusa.com
20 mg Blue, round, 7 mm, marked “020”
| Package | NDC |
|---|---|
| Bottle of 100 | 76385-133-01 |
| Bottle of 1000 | 76385-133-10 |
40 mg Blue, round, 9 mm, marked “021”
| Package | NDC |
|---|---|
| Bottle of 100 | 76385-134-01 |
| Bottle of 1000 | 76385-134-10 |
80 mg Blue, round, 9 mm, marked “021”
| Package | NDC |
|---|---|
| Bottle of 100 | 76385-135-01 |
| Bottle of 1000 | 76385-135-10 |
Inactive ingredients: FD&C Blue No. 2, starch, corn, magnesium stearate, cellulose, microcrystalline, citric acid monohydrate, copovidone, sodium starch glycolate type a corn
Has a dye: FD&C Blue No. 2
20 mg OFF-WHITE, round, 7 mm, marked “N / 20”
| Package | NDC |
|---|---|
| Carton of 10 | 68382-732-77 |
| Bottle of 90 | 68382-732-16 |
| Bottle of 100 | 68382-732-01 |
| Bottle of 1000 | 68382-732-10 |
40 mg YELLOW, round, 9 mm, marked “N / 40”
| Package | NDC |
|---|---|
| Carton of 10 | 68382-733-77 |
| Bottle of 90 | 68382-733-16 |
| Bottle of 100 | 68382-733-01 |
| Bottle of 1000 | 68382-733-10 |
80 mg BLUE, round, 11 mm, marked “N / 80”
| Package | NDC |
|---|---|
| Carton of 10 | 68382-734-77 |
| Bottle of 90 | 68382-734-16 |
| Bottle of 100 | 68382-734-01 |
| Bottle of 1000 | 68382-734-10 |
Inactive ingredients: anhydrous citric acid, cellulose, microcrystalline, magnesium stearate, povidone, silicon dioxide, sodium starch glycolate type a potato, starch, corn, ferric oxide yellow, FD&C Blue No. 2
Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.
Angina Pectoris
Nadolol tablets, USP is indicated for the long-term management of patients with angina pectoris.
Hypertension
Nadolol tablets, USP is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with Nadolol tablets, USP.
Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program's Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).
Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly.
Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.
Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy.
Nadolol tablets, USP may be used alone or in combination with other antihypertensive agents, especially thiazide-type diuretics.
Source: the FDA label for Nadolol (BluePoint Laboratories), April 9, 2025. Full label on DailyMed
Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/corgard/